1. Malaria

2. Background Definition of malaria Malaria is an infectious disease caused by protozoan organisms of the genus Plasmodium (falciparum, ovale, vivax, malariae). It is characterized by high fever and erythrocytic infection resulting in anemia..

3. life cycle: asexual phase (schizogony) sexual phase (sporogony)

4. human host There are four species of malaria that infect humans. All of them are transmitted in the same way, Mosquito bites human Sporozoites injected into human host during blood meal Sporozoites infect liver cells, develop into schizonts, which release merozoites into the blood stream by rupturing the liver cells. Merozoites penetrate red blood cells and form schizonts; red blood cells release merozoites Some merozoites differentiate into male gametocytes or female gametocytes. Gametocytes are taken in by mosquito from a blood meal. Mosquito stage Parasites undergo sexual reproduction, develop into oocysts which release sporozoites that invade the mosquito's salivary glands. And the cycle continues on……

5. Sporogonous Cycle : Mosquito Stages Gametocytes P. falciparum P. vivax P. ovale P. malariae Human Liver Stages Exo-erythrocytic (hepatic) Cycle: Human Blood Stages Erythrocytic Cycle: Malaria Lifecycle

6. Epidemiology Malaria is the most important cause of fever and morbidity in the tropical world.

7. Clinical Manifestations The clinical manifestations of malaria range from asymptomatic infection to fulminant illness and. Death.Febrile paroxysms classic symptoms of the febrile paroxysms of malaria include high fever, rigors, sweats, and V:48h o:48h m:72h headache.

8. :Relapse Short-term relapse Longterm relaps

9. Malaria: Clinical manifestations Febrile paroxysms have 3 classic stages – Cold stage Pt feels cold and has shaking chills - mins. prior to fever – Hot stage 41° Lassitude, loss of appetite, bone and joint aches Tachycardia, hypotension, cough, HA, back pain, N/V, diarrhea, abdo pain, altered consciousness – Sweating stage Marked diaphoresis followed by resolution of fever, profound fatigue, and sleepiness hours after onset of hot stage

10. Malaria: Clinical manifestations Other symptoms depend upon the strain of malaria P. vivax, ovale and malariae: few other sxs P. falciparum: – Dependent upon host immune status No prior immunity/splenectomy high levels of parasitemia : profound hemolysis – Vascular obstruction and hypoxia Kidneys: renal failure Brain: hypoxia, CNS dysfunction, coma, seizures Lungs: pulmonary edema – Jaundice and hemoglobinuria (blackwater fever)

11. Laboratory and Imaging Studies The diagnosis of malaria is established by identification of organisms on stained smears of peripherd blood. timing of the smears is less important than their being obtained several times each day over 3 successive days.. Thick smears are used to scan large numbers of. Erythrocytes quickly Thin smears allow for positive identification of the malaria species.

12. Diagnosis Key of diagnosis is to identify P. falciparum New assays: – ELISA for antigen, immunoassay for LDH, PCR Anemia, elevated LDH, increased reticulocytes, thrombocytopenia Elevated unconjugated bilirubin without increases in hepatic enzymes Elevated serum creatinine, proteinuria, hemoglobinuria, hypoglycemia

13. Differential Diagnosis the possibility of malaria in any child who has fever, chills, splenomegaly, anemia, or decreased level of consciousness with a history of recent travel or residence in an endemic area, regardless of the use of chemoprophylaxis. DDX: tuberculosis, typhoid fever, brucellosis, relapsing fever, infective endocarditis, influenza, polio, yellow fever, trypanosomiasis, kalaazar, and amebic liver abscess.

14. All Plusmudim Species Except Chloroquine-Resistant P. Falciparum Oral Drug of Choice chloroquine phosphate Parenteral Drug of Choice quinidine gluconate

15. chloroquine-Resistant P. Falciparum Oral drug of Choice Quinine sulfate plus tetracycline‘ Alterative Oral regimens: Quinine sulfate plus pyrimethamine-sulfadoxine Mefloquine Atovaquone Plus proguanil

16. chloroquine-Resistant P. Falciparum Parenteral Dnrg of Choice: Quinidine gluconate

17. Primaquine phosphate (after completion of chloroquine) Prevention of Relapses: P. viva and P. ovale

18. Complications Cerebral malaria : is a complication of P.falciparum infection and a frequent cause of death (20% to 40%), Especially among children and nonimmune adults occur among patients with intense parasitemia (~5%). Other complications include splenic rupture,renal failure, severe hemolysis (blackwater fever), pulmonary edema, hypoglycemia, thrombocytopenia, and algid malaria (sepsis syndrome with vascular collapse).

19. Prognosis Death may occur with any of the malarial species, is most frequent with complicated P. falciparum malaria. The likelihood of death is increased in children with preexisting health problems, such as measles, intestinal parasites, schistosomiasis, anemia, and malnutrition. Death is much more common in poor developing countries